Neuroendocrine tumours trials in United States

In United States 89 Also abroad 244

89 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Multicenter Study for External Validation of the TB-NET Score
Where
Boston, St Louis
Age
18 years and over
People
400 worldwide
Run by
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
See details and how to joinNCT07903532
Phase 3Enrolling by invitation
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
Where
Bay Shore, Houston, Kettering, Memphis
People
5,000
Run by
Exelixis
See details and how to joinNCT07620574 · EU 2026-525795-26-00
No phaseTaking people
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
Where
Sacramento
Age
18 years and over
People
9
Run by
University of California, Davis
See details and how to joinNCT05160480
Phase 1/2Not yet taking people in United States
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
Where
Lexington, Tampa, Washington D.C.
Age
18 years and over
People
60 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07707895 · EU 2026-525634-27-00
Phase 2Taking people
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
Where
Bethesda
Age
18 years to 100 years
People
130
Run by
National Cancer Institute (NCI)
See details and how to joinNCT03206060
Phase 1Taking people
A Study of Armored CAR T Cells in People With Cancer
Where
Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
Age
18 years and over
People
16
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07783477
Phase 1/2Taking people
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Where
Atlanta, Chicago, Cleveland, Glen Burnie, Houston, Omaha, Princeton, Tampa
Age
18 years and over
People
138
Run by
Molecular Partners AG
See details and how to joinNCT07278479
Phase 1Taking people
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Where
City of Saint Peters, Creve Coeur, Duarte, Irvine, Orange, Shiloh, St Louis
Age
18 years and over
People
24 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT05687123
Phase 2Not yet taking people in United States
Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
Where
Buffalo
Age
18 years and over
People
60
Run by
Roswell Park Cancer Institute
See details and how to joinNCT06202066
No phaseTaking people
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Where
Bethesda
Age
18 years and over
People
2,000
Run by
National Cancer Institute (NCI)
See details and how to joinNCT02146170
Phase 2Taking people
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
Where
Bethesda
Age
12 years and over
People
740
Run by
National Cancer Institute (NCI)
See details and how to joinNCT04074135
Phase 1/2Taking people
Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
Where
Bethesda
Age
18 years to 100 years
People
56
Run by
National Cancer Institute (NCI)
See details and how to joinNCT04086485
Phase 2Taking people
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
Where
Bethesda
Age
18 years to 120 years
People
45
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06228066
Phase 1/2Taking people
Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy
Where
Bethesda
Age
18 years to 120 years
People
66
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06427798
Phase 1Taking people
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
Where
Dallas, Hackensack, Houston, Nashville, New York, Seattle, St Louis
Age
18 years and over
People
110
Run by
Moonlight Bio, Inc
See details and how to joinNCT07488923
No phaseTaking people
A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
Where
East Hanover
Age
18 years to 110 years
People
4,023
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07635316
Phase 2Taking people
Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)
Where
Rochester, St Louis
Age
18 years and over
People
32
Run by
Washington University School of Medicine
See details and how to joinNCT06926634
Phase 1/2Taking people
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Where
Baltimore, Chapel Hill, Chicago, Cleveland, Columbus, Detroit, Fairfax, Grand Rapids, Iowa City, Jacksonville, Lexington, Miami, Milwaukee, Nashville, Omaha, Orlando, Rochester, Seattle, St Louis, Troy
Age
18 years to 90 years
People
300
Run by
Perspective Therapeutics
See details and how to joinNCT05636618
No phaseEnrolling by invitation
Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms
Where
Columbus
Age
18 years and over
People
12
Run by
Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07619417
Phase 2Taking people
CapTemY90 for Grade 2/3 NET Liver Metastases
Where
Buffalo, La Jolla, Miami, Philadelphia
Age
18 years and over
People
70
Run by
Abramson Cancer Center at Penn Medicine
See details and how to joinNCT04339036
Phase 1Not yet taking people in United States
211At-MABG in Adults With Advanced Neuroendocrine Cancers
Where
Philadelphia
Age
18 years and over
People
16
Run by
University of Pennsylvania
See details and how to joinNCT07661420
Phase 1Taking people
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Where
Bethesda
Age
18 years to 120 years
People
120
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06479811
Phase 1/2Taking people
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Where
Gilbert, Seattle, Tucson
Age
18 years to 99 years
People
30
Run by
University of Arizona
See details and how to joinNCT06814496
No phaseTaking people
DESTINY-PANTUMOUR04
Where
Birmingham, Boulder, Bullhead City, Canton, Casa Grande, Coral Springs, Dallas, Decatur, Durham, Farmington, Maumee, Nashville, Philadelphia, San Diego, St. Petersburg, Topeka, West Palm Beach, Wilson
Age
18 years to 130 years
People
100
Run by
AstraZeneca
See details and how to joinNCT07124000
Phase 1Taking people
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Where
Boston, Iowa City, Royal Oak, Seattle
Age
18 years to 100 years
People
116 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00